Idexx empowers veterinarians with new testing insights that support earlier diagnosis and intervention for preventive care and critical cases

Idexx reference laboratories will add fecal dx antigen testing with flea tapeworm detection,  testing for the fgf-23 kidney biomarker, and next-day pcr direct testing service westbrook, maine , june 21, 2022 /prnewswire/ -- idexx laboratories, inc. (nasdaq: idxx), a global leader in pet healthcare innovation, announces new reference laboratory tests and services to help veterinarians gain insights during wellness screenings, develop treatment plans for cats with chronic kidney disease, and access fast, definitive answers for the most critical cases. "the expansion of our reference laboratory menu demonstrates our continued focus on innovations that create clarity for our veterinary customers, supporting our shared mission to advance the standard of care for pets," said jay mazelsky, idexx president and chief executive officer.
IDXX Ratings Summary
IDXX Quant Ranking